Gemina Laboratories Ends Private Placement Transaction

Gemina Laboratories Ltd. has announced the termination of a previously announced non-brokered private placement. The company had intended to raise up to $7 million at a rate of $0.75 per share. However, it has been unable to close on this subscription and is now exploring other financing options.

In addition to this financial update, Gemina revealed changes to its board of directors. Martha Najib and Bola Grace have resigned. The company expressed gratitude for their service and wished them success in their future endeavors.

This announcement clarified that the securities involved are not registered for sale in the United States under the U.S. Securities Act of 1933.